APAC IPOs & Placements, Aequitas Research

Nicholas Tan

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Beijing Tongrentang Co A / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/beijing-tongrentang-co-ltd" target="_blank" data-smartkarma-citation="entities:20167:1" rel="noopener">Beijing Tongrentang Co A (600085 CH)</a> is looking to raise up to US$114m in its upcoming Hong Kong IPO.</li>
<li>Beijing Tong Ren Tang Healthcare Investment is China’s largest non-public TCM hospital group by patient visits.</li>
<li>In this note, we examine the IPO dynamics, and look at the firm’s valuation.</li>
</ul>



Beijing Tongrentang Co A (600085 CH) is looking to raise up to US$114m in its upcoming Hong Kong IPO.
Beijing Tong Ren Tang Healthcare Investment is China’s largest non-public TCM hospital group by patient visits.
In this note, we examine the IPO dynamics, and look at the firm’s valuation.


Aequitas: Beijing Tong Ren Tang IPO - Weak Track Record, Too Expensive Relative to Peers